In the past two decades, transcatheter aortic valve replacement (TAVR) has revolutionized the approach to aortic stenosis management. The technique has significantly evolved, expanding its application to younger, lower-risk patients with longer life expectancies and treating the disease at earlier stages. This progress has prompted the continuous evolution of device technology and minimized procedural complications….